Press releases, media coverage, testimonial videos, case reports, and articles
Official announcements, institutional updates, partnerships and scientific developments from btt.
Initial phase study marks the clinical evaluation of the Abreu BTT 700 TMS and its thermofebrile protocol, laying the foundation for future efficacy trials in the treatment of ALS and other neurodegenerative disorders.
First video-documented ALS reversal marks a new era for brain health achieved through noninvasive computerized brain-temperature modulation, confirmed by electrophysiological, molecular, and anatomical evidence.
Personal experiences from individuals whose journeys have been supported by btt Medical Institute and btt Wellness Institute.
Educational articles on brain thermodynamics, neurodegenerative conditions and personalized, physician-guided care.
Early symptoms of ALS can be subtle and are frequently mistaken for more common neuromuscular conditions.
Human sleep is fundamentally thermoregulatory. Small shifts in brain temperature shape recovery, cognition and repair.
Standardized treatments are necessary, but personalization often determines whether patients experience meaningful, sustained gains.
Anonymized case reports documenting objective outcomes, biomarker profiles and safety observations from btt-guided clinical care.
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS)
